Biomodels Attends Anti-Fibrotic Drug Development Summit 2018

Biomodels attends the Anti-Fibrotic Drug Development Summit, November 27-29, 2018.

Dr. Andrew Borkowski will present "A Murine Model of Systemic Sclerosis: Bleomycin Delivered by Osmotic Pump Causes DEvelopment of Pulmonary and Dermal Fibrosis." View Poster.

To learn about Biomodels preclinical capabilities and/or discuss a specific project you have in mind, Scientist Dr. Andrew Borkowski will be available to meet with you during the conference. To schedule a time to connect with Andrew please email Ashlee Graham (Business Development Manager) directly, and/or stop by Biomodels booth. 

Meeting location: Hyatt Regency Cambridge (Cambridge, MA)